These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35793124)

  • 21. Bone marrow transplantation in sickle cell anemia.
    Hoppe CC; Walters MC
    Curr Opin Oncol; 2001 Mar; 13(2):85-90. PubMed ID: 11224704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physical, Mental, and Social Health of Adult Patients with Sickle Cell Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Mixed-Methods Study.
    Dovern E; Nijland SJAM; van Muilekom MM; Suijk LMJ; Hoogendoorn GM; Mekelenkamp H; Biemond BJ; Haverman L; Nur E
    Transplant Cell Ther; 2023 Apr; 29(4):283.e1-283.e9. PubMed ID: 36634737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fatigue in Hematopoietic Cell Transplantation Survivors: Correlates, Care Team Communication, and Patient-Identified Mitigation Strategies.
    Ullrich CK; Baker KK; Carpenter PA; Flowers ME; Gooley T; Stevens S; Krakow EF; Oshima MU; Salit RB; Vo P; Connelly-Smith L; Lee SJ; Wood WA
    Transplant Cell Ther; 2023 Mar; 29(3):200.e1-200.e8. PubMed ID: 36494015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surveillance for Sickle Cell Disease - Sickle Cell Data Collection Program, Two States, 2004-2018.
    Snyder AB; Lakshmanan S; Hulihan MM; Paulukonis ST; Zhou M; Horiuchi SS; Abe K; Pope SN; Schieve LA
    MMWR Surveill Summ; 2022 Oct; 71(9):1-18. PubMed ID: 36201430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype.
    Hsieh MM; Fitzhugh CD; Weitzel RP; Link ME; Coles WA; Zhao X; Rodgers GP; Powell JD; Tisdale JF
    JAMA; 2014 Jul; 312(1):48-56. PubMed ID: 25058217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term Survival after Hematopoietic Cell Transplant for Sickle Cell Disease Compared to the United States Population.
    St Martin A; Hebert KM; Serret-Larmande A; Jouhet V; Hughes E; Stedman J; DeSain T; Pillion D; Lyons JC; Steinert P; Avillach P; Eapen M
    Transplant Cell Ther; 2022 Jun; 28(6):325.e1-325.e7. PubMed ID: 35302009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary caregiver decision-making in hematopoietic cell transplantation and gene therapy for sickle cell disease.
    Sinha CB; Bakshi N; Ross D; Loewenstein G; Krishnamurti L
    Pediatr Blood Cancer; 2021 Jan; 68(1):e28749. PubMed ID: 33034129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adding Centralized Electronic Patient-Reported Outcome Data Collection to an Established International Clinical Outcomes Registry.
    Cusatis R; Flynn KE; Vasu S; Pidala J; Muffly L; Uberti J; Tamari R; Mattila D; Mussetter A; Bruzauskas R; Chen M; Leckrone E; Myers J; Mau LW; Rizzo JD; Saber W; Horowitz M; Lee SJ; Burns LJ; Shaw B
    Transplant Cell Ther; 2022 Feb; 28(2):112.e1-112.e9. PubMed ID: 34757219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pilot Study of Donor-Engrafted Clonal Hematopoiesis Evolution and Clinical Outcomes in Allogeneic Hematopoietic Cell Transplantation Recipients Using a National Registry.
    Gillis N; Padron E; Wang T; Chen K; DeVos JD; Spellman SR; Lee SJ; Kitko CL; MacMillan ML; West J; Tang YH; Teng M; McNulty S; Druley TE; Pidala JA; Lazaryan A
    Transplant Cell Ther; 2023 Oct; 29(10):640.e1-640.e8. PubMed ID: 37517612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropsychological, behavioral, and quality-of-life outcomes in children and adolescents with sickle cell disease treated with nonmyeloablative matched sibling donor hematopoietic cell transplantation: A case series.
    Fay-McClymont TB; Monagel DA; Singh G; Schulte F; Brooks BL; MacAllister WS; Désiré N; Mineyko A; Vasserman M; Leaker MT; Truong TH; Shah R; Lewis VA; Yeates KO; Guilcher GMT
    Pediatr Blood Cancer; 2022 Oct; 69(10):e29893. PubMed ID: 35891584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hematopoietic stem cell transplant referral patterns for children with sickle cell disease vary among pediatric hematologist/oncologists' practice focus: A Sickle Cell Transplant Advocacy and Research Alliance (STAR) study.
    Meier ER; Abraham AA; Ngwube A; Janson IA; Guilcher GMT; Horan J; Kasow KA
    Pediatr Blood Cancer; 2021 Mar; 68(3):e28861. PubMed ID: 33405370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adverse psychological outcomes in long-term survivors of hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study (BMTSS).
    Sun CL; Francisco L; Baker KS; Weisdorf DJ; Forman SJ; Bhatia S
    Blood; 2011 Oct; 118(17):4723-31. PubMed ID: 21821714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced Long-Term Brain Magnetic Resonance Imaging Evaluation of Children with Sickle Cell Disease after Hematopoietic Cell Transplantation.
    Green NS; Bhatia M; Griffith EY; Qureshi M; Briamonte C; Savone M; Sands S; Lee MT; Lignelli A; Brickman AM
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):670-676. PubMed ID: 28089760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved Quality of Life of Patients With Sickle Cell Disease after Allogeneic Stem Cell Transplant: Another Indication for Transplant.
    Aljaafri BA; Albawardi MF; Alghamdi AY; Altowairgi KM; Alhoshan YS; Alahmari B; Alsadi H; Ahmed M; Alnahdi M; Aljubour Z; Alzahrani M
    Hematol Oncol Stem Cell Ther; 2023 Jul; 17(1):37-42. PubMed ID: 37581462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Linking the Center for International Blood and Marrow Transplant Research Registry to the California Cancer Registry and California Hospital Patient Discharge Data.
    Keegan THM; Brunson A; Cooley JJP; Schonfeld SJ; Meyer CL; Valcarcel B; Abrahao R; Wun T; Auletta J; Muffly L; Morton LM
    Transplant Cell Ther; 2022 Dec; 28(12):859.e1-859.e10. PubMed ID: 36174935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current Trends and Outcomes in Cellular Therapy Activity in the United States, Including Prospective Patient-Reported Outcomes Data Collection in the Center for International Blood and Marrow Transplant Research Registry.
    Cusatis R; Litovich C; Feng Z; Allbee-Johnson M; Kapfhammer M; Mattila D; Akinola I; Phelan R; Broglie L; Auletta JJ; Steinert P; Bolon YT; Akhtar O; Bloomquist J; Chen M; Devine SM; Bupp C; Hamadani M; Hengen M; Jaglowski S; Kaur M; Kuxhausen M; Lee SJ; Moskop A; Page KM; Pasquini MC; Rizzo D; Saber W; Spellman SR; Stefanski HE; Tuschl E; Yusuf R; Zhan K; Flynn KE; Shaw BE
    Transplant Cell Ther; 2024 Sep; 30(9):917.e1-917.e12. PubMed ID: 38944153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health-Related Quality of Life in Young Adult Survivors of Hematopoietic Cell Transplantation.
    Rotz SJ; Yi JC; Hamilton BK; Wei W; Preussler JM; Cerny J; Deol A; Jim H; Khera N; Hahn T; Hashmi SK; Holtan S; Jaglowski SM; Loren AW; McGuirk J; Reynolds J; Saber W; Savani BN; Stiff P; Uberti J; Wingard JR; Wood WA; Baker KS; Majhail NS; Syrjala KL
    Transplant Cell Ther; 2022 Oct; 28(10):701.e1-701.e7. PubMed ID: 35872304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ethical Challenges in Hematopoietic Cell Transplantation for Sickle Cell Disease.
    Nickel RS; Kamani NR
    Biol Blood Marrow Transplant; 2018 Feb; 24(2):219-227. PubMed ID: 28870775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enrollment Lessons from a Biological Assignment Study of Marrow Transplantation versus Standard Care for Adolescents and Young Adults with Sickle Cell Disease: Considerations for Future Gene and Cellular Therapy Trials.
    Krishnamurti L; Neuberg D; Sullivan KM; Smith S; Eapen M; Walters MC
    Transplant Cell Ther; 2023 Apr; 29(4):217-221. PubMed ID: 36270432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparing the Effectiveness of Education Versus Digital Cognitive Behavioral Therapy for Adults With Sickle Cell Disease: Protocol for the Cognitive Behavioral Therapy and Real-time Pain Management Intervention for Sickle Cell via Mobile Applications (CaRISMA) Study.
    Badawy SM; Abebe KZ; Reichman CA; Checo G; Hamm ME; Stinson J; Lalloo C; Carroll P; Saraf SL; Gordeuk VR; Desai P; Shah N; Liles D; Trimnell C; Jonassaint CR
    JMIR Res Protoc; 2021 May; 10(5):e29014. PubMed ID: 33988517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.